AzTrials
AzTrials

Cesarean Section ComplicationsNCT07049705

Factors Influencing Bradycardia During Spinal Anesthesia in Obstetric Patients Undergoing Cesarean Section

An observational study of Cesarean Section Complications, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The study titled "Factors Influencing Bradycardia During Spinal Anaesthesia in Obstetric Patients Undergoing Caesarean Section"" aims to investigate the causes and patterns of bradycardia in pregnant women receiving spinal anesthesia during cesarean deliveries. Read more about this study

Who is it for?
Ages 18 to 40 years
Conditions the study is for
Cesarean Section Complications
How many people
289 participants
Where
1 sitePakistan
Study dates
17 Mar 2025to 28 Feb 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: The research seeks to enhance the understanding of both patient-specific and procedural risk factors, contributing to improved clinical management, safer anesthesia practices, and better maternal-fetal outcomes. Ethical approval and informed consent protocols are included to ensure participant safety and data confidentiality.

Who may be able to join

  • Obstetric patients aged 18-40 years.
  • Undergoing elective or emergency cesarean sections under spinal anesthesia.
  • Classified as ASA Physical Status I or II (relatively healthy or with mild systemic disease).
  • Provided informed consent (either by the patient or legal guardian).

Who cannot join

  • Patients with pre-existing cardiac conditions (e.g., arrhythmias, conduction abnormalities).
  • Patients taking medications that affect heart rate, such as beta-blockers or calcium channel blockers.
  • Patients with contraindications to spinal anesthesia (e.g., coagulopathy, infection at the injection site).
  • Those undergoing combined spinal-epidural or general anesthesia.
  • Patients with incomplete medical records or unable to provide informed consent.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Maqsood Medical complex

    Peshawar, Khyber Pakhtunkhwa

Other trials in Pakistan

About this study

The study titled "Factors Influencing Bradycardia During Spinal Anaesthesia in Obstetric Patients Undergoing Caesarean Section"" aims to investigate the causes and patterns of bradycardia in pregnant women receiving spinal anesthesia during cesarean deliveries. Bradycardia, defined as a heart rate below 60 beats per minute, is a known complication of spinal anesthesia, often resulting from sympathetic blockade and unopposed parasympathetic activity. This condition may lead to hypotension, decreased cardiac output, and compromised fetal oxygenation.

Read the detailed description

The research seeks to enhance the understanding of both patient-specific and procedural risk factors, contributing to improved clinical management, safer anesthesia practices, and better maternal-fetal outcomes. Ethical approval and informed consent protocols are included to ensure participant safety and data confidentiality.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. structured questionnaire

    1. Section A: Demographic and Baseline Information Age, weight, height, gestational age, parity, medical history, medications.
    2. Section B: Anesthetic and Surgical Details Indication for cesarean (elective/emergency), baseline heart rate and BP, type/dose of anesthetic, sensory block level, fluid administration, blood loss.
    3. Section C: Intraoperative Hemodynamic Events Occurrence of bradycardia (HR < 60 bpm), lowest HR, time to bradycardia, associated hypotension, interventions used, maternal symptoms.
    4. Section D: Neonatal Outcomes

    Apgar scores at 1 and 5 minutes, NICU admission and reasons.

    Scoring:

    There is no numerical scoring system described. Instead:

    Responses are mostly categorical or numerical entries (e.g., Yes/No, HR value, BP value, Apgar score).

    Measured: 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2025
  2. Study start17 Mar 2025
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion28 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
289 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07049705
Sponsor's protocol ID
MSAHSW/Batch-Fall23/916
Status last verified
Jun 2025
First submitted
25 Jun 2025
Last updated
3 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cesarean Section Complications, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 3 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

structured questionnaire (time frame: 12 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in